Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Nanes

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Bone|June 13, 2013
Chronic low dose tumor necrosis factor-α (TNF) suppresses early bone accrual in young mice by inhibiting osteoblasts without affecting osteoclastsL C Gilbert, H Chen, X Lu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1993
Tumor necrosis factor alpha decreases 1,25-dihydroxyvitamin D3 receptors in osteoblastic ROS 17/2.8 cellsN Mayur, S Lewis, B D Catherwood, et al.
Molecular and Cellular Endocrinology|September 2, 1998
Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptorsJ L Fernandez-Martin, S Kurian, P Farmer, et al.
Endocrinology|December 1, 1989
Glucocorticoid and 1,25-dihydroxyvitamin D modulate the degree of adenosine 3',5'-monophosphate-dependent protein kinase isoenzyme I and II activation by parathyroid hormone in rat osteosarcoma cellsL Titus, J E Rubin, M S Nanes, et al.
Endocrinology|May 1, 1991
Tumor necrosis factor-alpha inhibits 1,25-dihydroxyvitamin D3-stimulated bone Gla protein synthesis in rat osteosarcoma cells (ROS 17/2.8) by a pretranslational mechanismM S Nanes, J Rubin, L Titus, et al.
Chest|December 14, 1999
Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal functionF Iqbal, J Michaelson, L Thaler, et al.
Endocrinology|August 1, 1990
Interferon-gamma inhibits 1,25-dihydroxyvitamin D3-stimulated synthesis of bone GLA protein in rat osteosarcoma cells by a pretranslational mechanismM S Nanes, J Rubin, L Titus, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 1, 1991
1,25-dihydroxyvitamin D reduces parathyroid hormone receptor number in ROS 17/2.8 cells and prevents the glucocorticoid-induced increase in these receptors: relationship to adenylate cyclase activationL Titus, E Jackson, M S Nanes, et al.
Bone and Mineral|December 1, 1993
Rat osteoblasts and ROS 17/2.8 cells contain a similar protein tyrosine phosphataseL Titus, L G Marzilli, J Rubin, et al.
The American Journal of the Medical Sciences|November 11, 1999
Usefulness of fructosamine for monitoring outpatients with diabetesG E Austin, R Wheaton, M S Nanes, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Bone|June 13, 2013
Chronic low dose tumor necrosis factor-α (TNF) suppresses early bone accrual in young mice by inhibiting osteoblasts without affecting osteoclastsL C Gilbert, H Chen, X Lu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1993
Tumor necrosis factor alpha decreases 1,25-dihydroxyvitamin D3 receptors in osteoblastic ROS 17/2.8 cellsN Mayur, S Lewis, B D Catherwood, et al.
Molecular and Cellular Endocrinology|September 2, 1998
Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptorsJ L Fernandez-Martin, S Kurian, P Farmer, et al.
Endocrinology|December 1, 1989
Glucocorticoid and 1,25-dihydroxyvitamin D modulate the degree of adenosine 3',5'-monophosphate-dependent protein kinase isoenzyme I and II activation by parathyroid hormone in rat osteosarcoma cellsL Titus, J E Rubin, M S Nanes, et al.
Endocrinology|May 1, 1991
Tumor necrosis factor-alpha inhibits 1,25-dihydroxyvitamin D3-stimulated bone Gla protein synthesis in rat osteosarcoma cells (ROS 17/2.8) by a pretranslational mechanismM S Nanes, J Rubin, L Titus, et al.
Chest|December 14, 1999
Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal functionF Iqbal, J Michaelson, L Thaler, et al.
Endocrinology|August 1, 1990
Interferon-gamma inhibits 1,25-dihydroxyvitamin D3-stimulated synthesis of bone GLA protein in rat osteosarcoma cells by a pretranslational mechanismM S Nanes, J Rubin, L Titus, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 1, 1991
1,25-dihydroxyvitamin D reduces parathyroid hormone receptor number in ROS 17/2.8 cells and prevents the glucocorticoid-induced increase in these receptors: relationship to adenylate cyclase activationL Titus, E Jackson, M S Nanes, et al.
Bone and Mineral|December 1, 1993
Rat osteoblasts and ROS 17/2.8 cells contain a similar protein tyrosine phosphataseL Titus, L G Marzilli, J Rubin, et al.
The American Journal of the Medical Sciences|November 11, 1999
Usefulness of fructosamine for monitoring outpatients with diabetesG E Austin, R Wheaton, M S Nanes, et al.
Pageof 4